These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 7242574)

  • 1. Thromboxane in ischemic heart disease.
    N Engl J Med; 1981 Jul; 305(2):106-7. PubMed ID: 7242574
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of the calcium antagonist diltiazem on the prostacyclin-thromboxane ratio in the plasma of ischemic heart disease patients].
    Brovkovich VM; Topchiĭ II; Abidov AA
    Vopr Med Khim; 1991; 37(2):37-9. PubMed ID: 1897189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prostacyclin-thromboxane system in children and adolescents with a high risk of developing ischemic heart disease].
    Akimova EV
    Vopr Med Khim; 1992; 38(2):47-9. PubMed ID: 1413633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of thromboxane A2 in myocardial ischemia in patients with coronary artery disease.
    Tada M; Kuzuya T; Inoue M; Kodama K; Fukushima M; Abe H
    Adv Myocardiol; 1980; 2():397-405. PubMed ID: 7423053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative determination of thromboxane synthesis in blood samples by video-densitometry.
    Jécsai G; Bagdány S
    Acta Biochim Biophys Acad Sci Hung; 1980; 15(4):259-61. PubMed ID: 7282294
    [No Abstract]   [Full Text] [Related]  

  • 6. Thromboxane A2 release and the injury-spasm hypothesis.
    Hellstrom HR
    Circulation; 1980 Sep; 62(3):667-8. PubMed ID: 7398033
    [No Abstract]   [Full Text] [Related]  

  • 7. Radioimmunoassay of thromboxane B2 in plasma of normal and asthmatic subjects.
    Morris HG; Sherman NA; Shepperdson FT; Selner JC
    Adv Prostaglandin Thromboxane Res; 1980; 8():1759-64. PubMed ID: 7377023
    [No Abstract]   [Full Text] [Related]  

  • 8. Radioimmunoassay of serum thromboxane B2: a simple method of assessing pharmacologic effects on platelet function.
    Patrono C; Ciabattoni G; Pugliese F; Pinca E; Castrucci G; De Salvo A; Satta MA; Parachini M
    Adv Prostaglandin Thromboxane Res; 1980; 6():187-91. PubMed ID: 7386257
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduced plasma thromboxane elevation during partial cardiopulmonary bypass in thrombocytopenic sheep.
    Wonders TR; Southmayd JR; Schuette AH; Huttemeier PC; Kong D; Watkins WD; Carvalho A; Zapol WM
    Trans Am Soc Artif Intern Organs; 1981; 27():276-9. PubMed ID: 7331082
    [No Abstract]   [Full Text] [Related]  

  • 10. Thromboxane B2 (TxB2) release during IgE anaphylaxis in the rabbit.
    McManus LM; Shaw JO; Pinckard RN
    J Immunol; 1980 Nov; 125(5):1950-4. PubMed ID: 7430618
    [No Abstract]   [Full Text] [Related]  

  • 11. [Association between lipoprotein(a) and coronary disease].
    Bovet P; Burnand B; Kappenberger L; Riesen W; Darioli R
    Schweiz Med Wochenschr; 1993 Nov; 123(45):2138-46. PubMed ID: 8266034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood rheological properties in chronic ischemic heart disease].
    Furkalo NK; Ivashchenko TI; Bolyshakova RM
    Klin Med (Mosk); 1981 Oct; 59(10):92-7. PubMed ID: 7311421
    [No Abstract]   [Full Text] [Related]  

  • 13. [Levels of thromboxane and prostacyclin in patients with systemic lupus erythematosus and antiphospholipid syndrome].
    Alekberova ZS; Reshetniak TM; Nasonov EL; Kalashnikova LA; Aleksandrova EN; Mach ZS; Rud'ko IA; Sushkevich GN; Kubatiev AA
    Klin Med (Mosk); 1994; 72(6):31-5. PubMed ID: 7898004
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rheological properties of the blood in chronic ischemic heart disease].
    Romanenko AI
    Vrach Delo; 1981 Mar; (3):76-81. PubMed ID: 7293149
    [No Abstract]   [Full Text] [Related]  

  • 15. White blood cell count and the incidence of ischemic stroke in coronary heart disease patients.
    Koren-Morag N; Tanne D; Goldbourt U
    Am J Med; 2005 Sep; 118(9):1004-9. PubMed ID: 16164887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration.
    Hedegaard SS; Hvas AM; Grove EL; Refsgaard J; Rocca B; Daví G; Kristensen SD
    Thromb Res; 2009 May; 124(1):96-100. PubMed ID: 19215971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood fibrinolytic system in health subjects and elderly patients with ischemic heart disease].
    Korkushko OV; Kovalenko AN
    Ter Arkh; 1980; 52(8):15-9. PubMed ID: 7256585
    [No Abstract]   [Full Text] [Related]  

  • 18. [Erythrocyte aggregation and the blood rheological properties in chronic ischemic heart disease].
    Progonnaia VV; Romanenko AI
    Vrach Delo; 1980 Oct; (10):54-7. PubMed ID: 7434707
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood lipid spectrum and blood coagulation indices in ischemic heart disease].
    Furkalo NK; Bol'shakova RM; Solovtsova KM
    Vrach Delo; 1981 Jun; (6):29-33. PubMed ID: 7257291
    [No Abstract]   [Full Text] [Related]  

  • 20. CD40 ligand and risk of ischemic stroke or coronary events in patients with chronic coronary heart disease.
    Tanne D; Haim M; Goldbourt U; Boyko V; Reshef T; Adler Y; Benderly M; Mekori YA; Behar S
    Int J Cardiol; 2006 Mar; 107(3):322-6. PubMed ID: 16503253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.